Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Estlander: the rocky ride for CTAs could ease moving into the fall

Friday, October 11, 2013

Bailey McCann, Opalesque New York:

Estlander & Partners is one of the oldest Nordic CTAs; started in 1991 it now manages approximately $850m. The firm focuses on three core strategies – the first is a price driven, trend based, short to medium term program. The second is a systematic micro strategy, and the third is a short term trading strategy with a combination of overlays.

Martin Estlander built the firm after finding success as an options market trader, and he recently sat down with Opalesque TV to discuss where he finds opportunity as a Nordic CTA.

He notes that apart from any specific trade or investment, the firm’s approach to risk management and trading discipline have been critical sources of support for the firm’s long term performance.

"The way we allocate risk is slightly different from the mainstream, it all goes back to thinking about how much money we can lose if everything really goes against us. We don’t make any sort of relation assumptions in our risk management."

"We are also very selective in our trading, we really look for high conviction trades to put on, so we are not as active as many others. But, when we go in with more conviction, we go in faster and can take slightly larger bets. That gives us an opportunity to capitalize on individual instruments."

Estlander explains that his team will enter a market very......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its